Concepedia

Mohamed Reda Keddar

MR

7

Publications

469

Citations

7

H-Index

2019

Active since

Affiliations

London Cancer(Current)

AstraZeneca (United States)

AstraZeneca (United Kingdom)

University College London

Cancer Research UK

Mohamed Reda Keddar is an author at London Cancer specializing in combinatorial optimization, engineering, and systems engineering.

Top concepts

Publications per year

2019–2025

7

Publications

7

Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

Danish Memon, Adam J. Schoenfeld, Darwin Ye et al. · Cancer Cell · 2024 · 146 citations · Full text

, , +19

Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts

Michele Bortolomeazzi, Mohamed Reda Keddar, Lucia Montorsi et al. · Gastroenterology · 2021 · 129 citations · Full text

Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial

Benjamin Besse, Elvire Pons‐Tostivint, Keunchil Park et al. · Nature Medicine · 2024 · 102 citations · Full text

A SIMPLI (Single-cell Identification from MultiPLexed Images) approach for spatially-resolved tissue phenotyping at single-cell resolution

Michele Bortolomeazzi, Lucia Montorsi, Damjan Temelkovski et al. · Nature Communications · 2022 · 44 citations · Full text

An efficient hybrid multi-objective memetic algorithm for the frequency assignment problem

Abd Errahmane Kiouche, Malika Bessedik, Fatima Benbouzid-Sitayeb et al. · Engineering Applications of Artificial Intelligence · 2019 · 21 citations

, , +10

Rows per page

1–5 of 7